Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Armuzzi

Showing results (51-60 of 320) with videos related to

Pageof 32
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2019
Risk factors and timing for colectomy in chronically active refractory ulcerative colitis: A systematic reviewFabio Salvatore Macaluso, Flaminia Cavallaro, Carla Felice, et al.
Journal of Crohn'S & Colitis|November 22, 2024
Low Incidence of Macular Edema and Other Ocular Events in the Etrasimod Development ProgramMarla C Dubinsky, Joseph Wu, Aoibhinn McDonnell, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 30, 2016
Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel DiseaseAlessandro Armuzzi, Paolo Gionchetti, Marco Daperno, et al.
Biomedicines|July 27, 2022
Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the IntestineArianna Dal Buono, Roberto Gabbiadini, Ludovico Alfarone, et al.
Frontiers in Cardiovascular Medicine|June 1, 2023
Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the <i>heart</i> of the issueRoberto Gabbiadini, Arianna Dal Buono, Elisabetta Mastrorocco, et al.
Clinical and Experimental Gastroenterology|August 1, 2022
Critical Appraisal of Filgotinib in the Treatment of Ulcerative Colitis: Current Evidence and Place in TherapyArianna Dal Buono, Roberto Gabbiadini, Virginia Solitano, et al.
Journal of the Anus, Rectum and Colon|October 30, 2024
Collagen Paste Injection in Crohn's Disease Perianal Fistula: Long-term Outcomes of a Pilot, Prospective Cohort StudyCarlotta La Raja, Annalisa Maroli, Caterina Foppa, et al.
BMC Psychology|November 29, 2021
Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: an Italian consensus statementGuendalina Graffigna, Caterina Bosio, Francesco Pagnini, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 3, 2021
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel DiseaseDaniela Pugliese, Giuseppe Privitera, Tommaso Schepis, et al.
World Journal of Gastroenterology|January 24, 2022
Orphan patients with inflammatory bowel disease - when we treat beyond evidenceGiuseppe Privitera, Daniela Pugliese, Loris Riccardo Lopetuso, et al.
Pageof 32

Showing results (51-60 of 320) with videos related to

Sort By:
Pageof 32
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2019
Risk factors and timing for colectomy in chronically active refractory ulcerative colitis: A systematic reviewFabio Salvatore Macaluso, Flaminia Cavallaro, Carla Felice, et al.
Journal of Crohn'S & Colitis|November 22, 2024
Low Incidence of Macular Edema and Other Ocular Events in the Etrasimod Development ProgramMarla C Dubinsky, Joseph Wu, Aoibhinn McDonnell, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 30, 2016
Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel DiseaseAlessandro Armuzzi, Paolo Gionchetti, Marco Daperno, et al.
Biomedicines|July 27, 2022
Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the IntestineArianna Dal Buono, Roberto Gabbiadini, Ludovico Alfarone, et al.
Frontiers in Cardiovascular Medicine|June 1, 2023
Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the <i>heart</i> of the issueRoberto Gabbiadini, Arianna Dal Buono, Elisabetta Mastrorocco, et al.
Clinical and Experimental Gastroenterology|August 1, 2022
Critical Appraisal of Filgotinib in the Treatment of Ulcerative Colitis: Current Evidence and Place in TherapyArianna Dal Buono, Roberto Gabbiadini, Virginia Solitano, et al.
Journal of the Anus, Rectum and Colon|October 30, 2024
Collagen Paste Injection in Crohn's Disease Perianal Fistula: Long-term Outcomes of a Pilot, Prospective Cohort StudyCarlotta La Raja, Annalisa Maroli, Caterina Foppa, et al.
BMC Psychology|November 29, 2021
Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: an Italian consensus statementGuendalina Graffigna, Caterina Bosio, Francesco Pagnini, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 3, 2021
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel DiseaseDaniela Pugliese, Giuseppe Privitera, Tommaso Schepis, et al.
World Journal of Gastroenterology|January 24, 2022
Orphan patients with inflammatory bowel disease - when we treat beyond evidenceGiuseppe Privitera, Daniela Pugliese, Loris Riccardo Lopetuso, et al.
Pageof 32